In fact, a promising new FAP-targeting CAR-T cell has been shown to loosen the desmoplasia that restricts T cell invasion into tumors, which enables other tumor-targeting CAR-T cells to be used to finish the job and shrink the tumor [5]. The gene discussed is FAP; the disease is neoplasm.